Form 4: Unity Biotechnology CEO Sells Shares to Cover Tax Obligations

Anirvan Ghosh, CEO of Unity Biotechnology, sold 604 shares of common stock on August 2, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

• On August 2, 2024, Anirvan Ghosh, the CEO of Unity Biotechnology, sold 604 shares of the company's common stock.
• The sale was executed at a price of $1.53 per share.
• The transaction was conducted under a Rule 10b5-1 trading plan.
• The purpose of the sale was to cover tax withholding obligations arising from the vesting of Restricted Stock Units (RSUs).
• Following the transaction, Ghosh directly owns 76,325 shares, which includes unvested Restricted Stock Units.

Sentiment

Score: 6

Explanation: The document is a routine SEC filing related to stock sales for tax purposes. It doesn't indicate any significant positive or negative sentiment.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives. The use of a 10b5-1 trading plan suggests the sales were pre-planned.

Stakeholder Impact

• The sale of shares by the CEO could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates